Mekophar Chemical Pharmaceutical JSC Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'11
Dec'10
No of Months
12
12
12
12
Profit Before Tax
53,134.00
43,314.00
100,923.00
92,557.00
Adjustment
0.00
0.00
0.00
0.00
Changes In working Capital
-45,203.00
62,021.00
-83,032.00
-105,161.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
62,837.00
103,400.00
36,394.00
6,634.00
Cash Flow from Investing Activities
-6,772.00
-2,304.00
-18,540.00
8,531.00
Cash Flow from Financing Activities
-12,634.00
-33,278.00
-30,761.00
-18,121.00
Net Cash Inflow / Outflow
43,663.00
68,048.00
-12,907.00
-2,956.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
232.00
231.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
Figures in VND Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Mekophar Chemical Pharmaceutical JSC
Figures in Million
consolidated Cash Flow Results
Change(VND)
Change(%)
Profit Before Tax
53134.785677
19337.915777
33,797.00
174.77%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-45203.133376
10001.348251
-55,204.00
-551.97%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
62837.048196
35640.856639
27,197.00
76.31%
Cash Flow from Investing Activities
-6772.677171
8915.15895
-15,687.00
-175.97%
Cash Flow from Financing Activities
-12634.1105
-45478.485152
32,844.00
72.22%
Net Cash Inflow / Outflow
43663.112395
-922.469563
44,585.00
4833.28%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
232.85187
0
232.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -39.23% vs NA in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
62,837.05
1,03,400.10
-39.23%






